Fundz

Austrian Biotech Heartbeat.Bio Secures €4.5M For Cardioid Drug Discovery Platform

PRIVATENov 02, 2023

Amount Raised

€4.5 Million

Round Type

Seed

ViennaBiotechnologyHealth CareMedicalPharmaceutical

Investors

Tensor VenturesAws Gründungsfonds IiInvest AGI&I Biotech Fund

Description

Austrian biotech startup HeartBeat.bio has secured a € 4.5 million Pre-series A round

Quick answer

HeartBeat.bio raised €4.5 Million in a Seed round, dated November 2, 2023. Investors: Tensor Ventures, Aws Gründungsfonds Ii, Invest AG and I&I Biotech Fund. HeartBeat.bio is based in Vienna, Vienna, Austria.

How much did HeartBeat.bio raise?
HeartBeat.bio raised €4.5 Million in a Seed round on November 2, 2023.
Who invested in HeartBeat.bio?
Tensor Ventures, Aws Gründungsfonds Ii, Invest AG and I&I Biotech Fund are named as investors in this round.
What does HeartBeat.bio do?
HeartBeat.bio is a VC funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.
Where is HeartBeat.bio based and how big is it?
HeartBeat.bio is based in Vienna, Vienna, Austria.
Who are the decision-makers at HeartBeat.bio?
Fundz holds 1 contact at HeartBeat.bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Pharmaceutical around the same time

Companies in the same sectors as HeartBeat.bio that raised within 45 days of this round, from Fundz verified event records.

  • MBrace Therapeutics raised $85M (Series B) on November 14, 2023.
  • Lipella Pharmaceuticals raised $3.1M (Seed) on October 23, 2023.
  • Greenbrook TMS raised $4M (Seed) on December 15, 2023.
  • Procyrion raised $58M on December 13, 2023.
  • Laza Medical raised $36M (Series A) on December 12, 2023.
  • Os Therapies raised $700K on December 8, 2023.

Who to call at HeartBeat.bio, and when

A new round usually means HeartBeat.bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day HeartBeat.bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at HeartBeat.bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at HeartBeat.bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

HeartBeat.bio

Location

Vienna, Vienna, Austria

About

HeartBeat.bio is a VC funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies. Our core technology is based on the world-wide first, self-organizing cardiac organoids (Cardioids) which resemble the human physiology of a human heart chamber in a way that allows for the cost-efficient and large scale in-vitro analysis of crucial clinical parameters associated with various cardiac diseases. The Cardioid-based screening platform has the potential to radically change the current cardiovascular drug discovery paradigm.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment HeartBeat.bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for HeartBeat.bio's next move

See what Strategic adds

HeartBeat.bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.